Medical Cannabis and Anxiety: What the Evidence Actually Shows
Anxiety can involve persistent worry, fear, physical tension, racing thoughts, sleep problems, and difficulty concentrating. Treatments such as psychotherapy, medication, and lifestyle changes can help, but interest in cannabis-based products has grown among people looking for alternatives or additions to conventional care.
The evidence, however, does not yet support describing medical cannabis as an established treatment for anxiety. Research suggests that the effects can vary substantially according to the cannabinoid, dose, product, route of administration, and individual response.
What the research says
A frequently cited source is the 2018–2019 Cannabis as Medicine Survey (CAMS-18), an online Australian survey of 1,388 adults who said they had used cannabis for therapeutic reasons. Participants reported using cannabis for a range of conditions, most commonly pain, mental health concerns, and sleep problems.
The survey found that pain was the main condition treated by 36.4% of respondents, followed by mental health conditions at 32.8%. Anxiety was reported as one of the conditions treated by approximately one-third of participants. Many respondents also said their symptoms improved, but the study did not test a standardized cannabis medicine against a placebo or another treatment.
That distinction is important. CAMS-18 was a cross-sectional survey based on self-reported experiences and a convenience sample recruited largely online. Most participants obtained cannabis outside the legal prescription system, and the researchers noted uncertainty about the products’ potency, contents, and possible contamination. The findings show why people use cannabis and how they perceive its effects; they do not demonstrate that cannabis caused anxiety symptoms to improve.
THC and CBD may affect anxiety differently
Cannabis contains many compounds, but the two most studied are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is intoxicating and can produce relaxation for some people, but it can also cause increased heart rate, uncomfortable thoughts, anxiety, or paranoia—particularly at higher doses or in people who are inexperienced with cannabis.
CBD does not produce the same intoxicating effect as THC, but its potential role in anxiety treatment remains uncertain. A 2022 systematic review of cannabinoid treatments for anxiety found some evidence of reduced anxiety in certain settings, while also emphasizing that the ideal dose, formulation, treatment duration, and clinical population remain unclear. The review noted that effects may follow an “inverted U-shaped” pattern, meaning that more is not necessarily better.
Another review of THC and CBD research found that THC more often produced anxiety-like effects in controlled studies, while findings for CBD were mixed. Some studies have reported benefits in laboratory tests or small clinical groups, but these results cannot automatically be applied to people with generalized anxiety disorder, panic disorder, social anxiety disorder, or other diagnosed conditions.
Why the endocannabinoid system does not settle the question
The endocannabinoid system is involved in several processes, including mood, stress responses, sleep, appetite, and immune function. This provides a biological reason to study cannabinoids as possible medicines, but a plausible mechanism is not proof that a product will safely or effectively treat an anxiety disorder.
Much more clinical research is needed, especially well-designed trials involving people with diagnosed anxiety disorders. Studies should compare clearly defined products and doses with placebo or established treatments, measure long-term outcomes, and monitor side effects and dependence.
Potential risks and practical cautions
People should not assume that a product marketed as “medical,” “natural,” or “CBD-rich” is automatically safe or effective. The U.S. Food and Drug Administration has not approved cannabis to treat anxiety or any other disease. FDA-approved cannabis-related medicines have specific indications, standardized manufacturing, and medical supervision; most products sold in dispensaries, stores, or online do not undergo the same federal review.
CBD can interact with prescription medicines and has been associated with risks such as liver injury and excessive sleepiness. THC-containing products may impair judgment and coordination, and cannabis use can worsen anxiety or paranoia in some people. The Centers for Disease Control and Prevention notes that cannabis can cause unpleasant feelings of anxiety and paranoia and is associated with several mental health concerns.
Anyone considering cannabis for anxiety should discuss it with a qualified healthcare professional, particularly when taking antidepressants, sedatives, or other medications; when there is a personal or family history of psychosis or substance-use disorder; or during pregnancy or breastfeeding. Cannabis should not replace an evaluation for persistent anxiety or delay evidence-based care.
The bottom line
Some people report short-term relief after using cannabis, but personal accounts and surveys cannot establish that cannabis is an effective treatment for anxiety. Current evidence is limited and inconsistent, with THC capable of reducing or intensifying anxiety depending on the circumstances and CBD showing uncertain benefits.
For diagnosed anxiety disorders, evidence-based psychotherapy such as cognitive behavioral therapy, medication when appropriate, or a combination of treatments remains the better-established approach. Cannabis may be a subject for careful discussion with a clinician, but it should not be presented as a proven or universally suitable therapy.
